Accelera Innovations (ACNV) 10-Q 11 Aug 17 2017 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2017	Aug. 11, 2017
Document And Entity Information
Entity Registrant Name	ACCELERA INNOVATIONS, INC.
Entity Central Index Key	1,444,144
Document Type	10-Q
Document Period End Date	Jun. 30, 2017
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		81,407,673
Trading Symbol	ACNV
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2,017

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2017	Dec. 31, 2016
Current Assets:
Cash
Accounts receivable, net		2,750
Total current assets		2,750
Property and equipment, net	5,889	6,889
TOTAL ASSETS	5,889	9,639
Current Liabilities:
Short-term notes payable	886,166	886,166
Advances from related party	435,592	403,092
Accounts payable	483,803	465,379
Accrued expenses	339,684	333,471
Convertible note, net of discount of $0 and $19,395	165,309	155,277
Derivative liability	168,067	149,269
Total current liabilities	2,478,621	2,392,654
Commitment and contingencies (Note 12)
STOCKHOLDERS' DEFICIT
Preferred stock, value
Common stock, $0.0001 par value, 100,000,000 shares authorized, 81,407,673 and 69,569,444 shares issued and outstanding at June 30, 2017 and December 31, 2016	8,140	6,957
Additional paid-in capital	59,254,792	59,222,837
Accumulated deficit	(61,735,684)	(61,612,829)
Total stockholders' deficit	(2,472,732)	(2,383,015)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	5,889	9,639
8% Convertible Preferred Stock [Member]
STOCKHOLDERS' DEFICIT
Preferred stock, value	$ 20	$ 20

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	Jun. 30, 2017	Dec. 31, 2016
Convertible debt current, net of discount	$ 0	$ 19,395
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	100,000,000	100,000,000
Common Stock, shares issued	81,407,673	69,569,444
Common stock, shares outstanding	81,407,673	69,569,444
8% Convertible Preferred Stock [Member]
Preferred stock, par value	$ 4	$ 4
Preferred stock, shares authorized	500,000	500,000
Preferred stock, shares issued	198,473	198,473
Preferred stock, shares outstanding	198,473	198,473

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016	Dec. 31, 2016
Income Statement [Abstract]
Revenues
Cost of revenues
Gross profit
Operating expenses:
General and administrative expenses	34,175	416,059	82,175	1,121,219
Total operating expenses	34,175	416,059	82,175	1,121,219
Loss from operations	(34,175)	(416,059)	(82,175)	(1,121,219)
Other income (expense)
Interest expense and financing costs	(5,319)	(195,694)	(21,882)	(286,170)
Change in fair value of derivative liability	(7,862)	39,385	(18,798)	92,922
Total other income (expenses)	(13,181)	(156,309)	(40,680)	(193,248)
Loss before provision for taxes	(47,356)	(572,368)	(122,855)	(1,314,467)
Provision for income taxes
Net loss	(47,356)	(572,368)	(122,855)	(1,314,467)	$ (1,925,294)
Preferred stock dividend	15,835	15,835	31,495	31,669
Net loss attributed to common stockholders	$ (63,191)	$ (588,203)	$ (154,350)	$ (1,346,136)
Weighted average shares outstanding - basic and diluted	80,447,453	46,761,216	78,768,026	45,950,776
Loss per share - basic and diluted	$ 0	$ (0.01)	$ 0	$ (0.03)

Condensed Consolidated Stateme5

Condensed Consolidated Statement of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
OPERATING ACTIVITIES:
Net loss	$ (122,855)	$ (1,314,467)
Adjustments to reconcile net loss to  net cash used in operating activities:
Depreciation	1,000	1,000
Stock options expense	15,000	921,144
Amortization of debt discount	19,395	122,474
Change in fair value of derivative liability	18,798	(92,922)
Financing costs associated with convertible note		135,533
Change in current assets and liabilities:
Accounts receivable	2,750
Prepaid expenses and other current assets		150
Accounts payable	18,424	(10,504)
Accrued expenses	14,988	11,354
Net cash used in operating activities	(32,500)	(226,238)
FINANCING ACTIVITIES:
Proceeds from convertible notes		77,500
Payment on notes payable		(18,700)
Cash overdraft		442
Advances from (payments to) related parties	32,500	166,996
Net cash provided by financing activities	32,500	226,238
NET DECREASE IN CASH
CASH, BEGINNING BALANCE
CASH, ENDING BALANCE
CASH PAID FOR:
Interest
Income taxes
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Convertible notes and accrued interest converted to common stock	$ 18,138	$ 24,000

Organization and Basis of Prese

Organization and Basis of Presentation	6 Months Ended
	Jun. 30, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Basis of Presentation	NOTE 1 – ORGANIZATION AND BASIS OF PRESENTATION Accelera Innovations, Inc., formerly Accelerated Acquisitions IV, Inc. (the “Company”) was incorporated in the State of Delaware on April 29, 2008 for the purpose of raising capital intended to be used in connection with its business plan which may include a possible merger, acquisition or other business combination with an operating business. On June 13, 2011, Synergistic Holdings, LLC (“Synergistic”) agreed to acquire 17,000,000 shares of the Company’s common stock, par value $0.0001 per share. At the same time, Accelerated Venture Partners, LLC agreed to tender 3,750,000 of its 5,000,000 shares of the Company’s common stock, par value $0.0001 per share, for cancellation. Following these transactions, Synergistic owned 93.15% of the Company’s 18,250,000 issued and outstanding shares of common stock, par value $0.0001 per share, and the interest of Accelerated Venture Partners, LLC was reduced to approximately 6.85% of the total issued and outstanding shares. Concurrent with the share purchase, Timothy Neher resigned from the Company’s Board of Directors and John Wallin was appointed to the Company’s Board of Directors. Such action represented a change of control of the Company. On October 18, 2011, the Company filed a Certificate of Amendment to its Certificate of Incorporation with the Secretary of State of Delaware and changed its name from Accelerated Acquisition IV, Inc. to Accelera Innovations, Inc. The Company is a healthcare service company which is focused on acquiring companies primarily in the post-acute care patient services and information technology services industries. The Company currently owns SCI Home Health, Inc. (d/b/a Advance Lifecare Home Health) (“SCI”), which offers personal care to patients in the Chicago, Illinois area. The accompanying consolidated financial statements and have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”). The unaudited interim condensed consolidated financial statements have been prepared by us pursuant to the rules and regulations of the Securities and Exchange Commission. The information furnished herein reflects all adjustments (consisting of normal recurring accruals and adjustments) which are, in the opinion of management, necessary to fairly present the operating results for the respective periods. Certain information and footnote disclosures normally present in the annual consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been omitted pursuant to such rules and regulations. These unaudited condensed consolidated interim financial statements should be read in conjunction with the audited consolidated financial statements and notes for the year ended December 31, 2016. The results of the six months ended June 30, 2017 are not necessarily indicative of the results to be expected for the full year ending December 31, 2017.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2017
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES PRINCIPLES OF CONSOLIDATION - The Company operates companies in the personal health care industry. The Company operates out of one service center serving the Chicago, Illinois area. The consolidated financial statements for the year ended December 31, 2016 include the accounts of the Company and its 100% owned subsidiary SCI, Significant intercompany accounts and transactions have been eliminated in consolidation. USE OF ESTIMATES – The preparation of unaudited condensed consolidated interim financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates in these financial statements include allowance for doubtful accounts, the valuation of intangibles, valuation allowance for deferred taxes, estimated useful life of property and equipment and the fair value of stock and options issues for services and interest. CASH - All cash is maintained with a major financial institution in the United States. Deposits with this bank may exceed the amount of insurance provided on such deposits. Temporary cash investments with an original maturity of three months or less are considered to be cash equivalents. The Company had no cash equivalents as of June 30, 2017 and December 31, 2016, respectively. The Company has not suffered any credit issues when deposits have exceeded the amount of insurance provided for such deposits. ACCOUNTS RECEIVABLE – Accounts receivable are recorded at estimated value, net of allowance for doubtful accounts. Accounts receivable are not interest bearing. The allowance for doubtful accounts is based upon management’s best estimate and past collection experience. For most accounts greater than 180 days, the Company carries a 100% allowance. Uncollectible accounts are charged off when all reasonable efforts to collect the accounts have been exhausted. PROPERTY AND EQUIPMENT– Property and equipment is stated at cost. Depreciation is provided on a straight line basis over the estimated useful lives of the assets. Maintenance and repairs are charged to expense as incurred; major renewals and betterments are capitalized. When items of property and equipment are sold or retired, the related cost and accumulated depreciation are removed from the accounts, and any gain or loss is included in income. DERIVATIVE FINANCIAL INSTRUMENTS — The Company evaluates all of its agreements to determine if such instruments have derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses the Black-Scholes-Merton option pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. As of June 30, 2017 and December 31, 2016, the Company’s only derivative financial instrument was an embedded conversion feature associated with convertible notes due to the conversion price being a percentage of the market price of the Company’s common stock. PREFERRED STOCK SUBSCRIPTION PAYABLE – During the years ended December 31, 2014 and 2013, an affiliate of the Company entered into subscription agreements with 13 investors. Pursuant to the terms of the subscription agreements, the affiliate agreed to issue shares of the Company’s 8% Convertible Preferred Stock that it was authorized to issue as of May 7, 2015. In exchange, the Company received aggregate proceeds from the investors of $652,462. Accordingly, the Company is obligated to issue an aggregate of 198,473 shares of 8% Convertible Preferred Stock to the investors with a stated value of $4.00 per share or an aggregate of $793,892. The net proceeds of $652,462 have been received by or on behalf of the Company and recorded as preferred stock subscription payable net of $141,430 of original issue discount related to such offering which amount was expensed. Upon obtaining the Certificate of Designation for the 8% Convertible Preferred Stock on May 7, 2015, the Company has included the aggregate amount of $793,892 of preferred stock as part of stockholders’ equity. Prior to May 7, 2015, the preferred stock subscription payable was included as a current liability. COMMON STOCK - The Company records common stock issuances when all of the legal requirements for the issuance of such common stock have been satisfied. REVENUE RECOGNITION - Revenue related to services and administrative support services is recognized ratably at the time services have been performed and pre-approved by payer. Gross service revenue is recorded in the accounting records on an accrual basis at the provider’s established rates, regardless of whether the health care entity expects to collect that amount. The Company will reserve a provision for contractual adjustment and discounts and deducts the provision from gross service revenue. The Company believes that recognizing revenue at the time the services have been performed because the Company’s revenue policies meet the following four criteria in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 605-10-S25, Revenue Recognition COST OF REVENUES - Costs of revenues are comprised of fees paid to members of the Company’s medical staff, other direct costs including transcription, film and medical record obtainment and transportation; and other indirect costs including labor and overhead related to the generation of revenues. ADVERTISING COSTS - The Company’s policy regarding advertising is to expense advertising when incurred. INCOME TAXES - The Company accounts for income taxes in accordance with ASC Topic 740, Income Taxes Under ASC 740, a tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded. The adoption had no effect on the Company’s consolidated financial statements. STOCK BASED COMPENSATION - The Company has share-based compensation plans under which employees, consultants, suppliers and directors may be granted restricted stock, as well as options and warrants to purchase shares of Company common stock at the fair market value at the time of grant. Stock-based compensation cost to employees is measured by the Company at the grant date, based on the fair value of the award, over the requisite service period under ASC 718. For options issued to employees, the Company recognizes stock compensation costs utilizing the fair value methodology over the related period of benefit. Grants of stock to non-employees and other parties are accounted for in accordance with the ASC 505 at measurement date. For awards with service or performance conditions, the Company generally recognize expense over the service period or when the performance condition is met. LOSS PER SHARE - Basic loss per share is computed by dividing net loss attributable to common stockholders by the weighted average common shares outstanding for the period. Diluted loss per share is computed giving effect to all potentially dilutive common shares. Potentially dilutive common shares may consist of incremental shares issuable upon the exercise of stock options and warrants and the conversion of notes payable to common stock. In periods in which a net loss has been incurred, all potentially dilutive common shares are considered anti-dilutive and thus are excluded from the calculation. FINANCIAL INSTRUMENTS - FASB Accounting Standards Codification (ASC) 820 Fair Value Measurements and Disclosures ● Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. ● Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means. ● Level 3 - Inputs that are both significant to the fair value measurement and unobservable. Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of June 30, 2017 and December 31, 2016. The Company uses Level 2 inputs for its valuation methodology for its derivative liability as its fair value was determined by using the Black-Scholes-Merton pricing model based on various assumptions. The Company’s derivative liability is adjusted to reflect fair value at each period end, with any increase or decrease in the fair value being recorded in results of operations as adjustments to fair value of derivatives. At June 30, 2017 and December 31, 2016, the Company identified the following liability that is required to be presented on the balance sheet at fair value (see Note 8): Fair Value Fair Value Measurements at As of June 30, 2017 Description June 30, 2017 Using Fair Value Hierarchy Level 1 Level 2 Level 3 Derivative liability - conversion feature $ 168,067 $ - 168,067 - Total $ 168,067 $ - 168,067 - Fair Value Fair Value Measurements at As of December 31, 2016 Description December 31, 2016 Using Fair Value Hierarchy Level 1 Level 2 Level 3 Derivative liability - conversion feature $ 149,269 $ - 149,269 - Total $ 149,269 $ - 149,269 - RECENT ACCOUNTING PRONOUNCEMENTS In January 2017, the FASB issued Accounting Standards Update (“ASU”) 2017-01, Business Combinations (Topic 805) Clarifying the Definition of a Business In November 2016, the FASB issued ASU 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash, In October 2016, the FASB issued ASU 2016-16, Income Taxes (Topic 740): Intra-Entity Transfer of Assets Other than Inventory In August 2016, the FASB issued ASU 2016-15 , Statement of Cash Flows (Topic 230), Classification of Certain Cash Receipts and Cash Payments In March 2016, the FASB issued ASU 2016-09, Stock Compensation (Topic 718), Improvements to Employee Share-Based Payment Accounting In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842 In August 2014, the FASB issued ASU 2014-15, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers Management does not believe that any recently issued, but not yet effective, accounting standards could have a material effect on the accompanying financial statements. As new accounting pronouncements are issued, the Company will adopt those that are applicable under the circumstances. RECLASSIFICATIONS - Certain prior year amounts have been reclassified to conform to the current period presentation. These reclassifications had no impact on net earnings, financial position or cash flows.

Balance Sheet Information

Balance Sheet Information	6 Months Ended
	Jun. 30, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Balance Sheet Information	NOTE 3 - BALANCE SHEET INFORMATION PROPERTY AND EQUIPMENT, NET Property and equipment, net at June 30, 2017 and December 31, 2016 consist of the following: June 30, 2017 December 31, 2016 Furniture and fixtures $ 3,940 $ 3,940 Office equipment 5,641 5,641 9,581 9,581 Less accumulated depreciation (3,692 ) (2,692 ) Property and equipment, net $ 5,889 $ 6,889 Depreciation expense for the six months ended June 30, 2017 and 2015 was $1,000 and $1,000, respectively.

Going Concern

Going Concern	6 Months Ended
	Jun. 30, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern	NOTE 4 - GOING CONCERN The accompanying unaudited condensed consolidated interim financial statements have been prepared assuming that the Company will continue as a going concern. The Company has incurred a net loss for the six months ended June 30, 2017 and the year ended December 31, 2016 of $122,855 and $1,925,294, respectively, and had an accumulated deficit of $61,735,684 as of June 30, 2017. In view of these matters, the Company’s ability to continue as a going concern is dependent upon the Company’s ability to add profitable operating companies and to achieve a level of profitability. The Company intends on financing its future development activities and its working capital needs largely from the sale of public equity securities with some additional funding from other traditional financing sources, including term notes until such time that funds provided by operations are sufficient to fund working capital requirements. The Company’s only operating subsidiary is SCI. Revenues from SCI have significantly decreased primarily due to the sudden departure of the administrator of SCI. The Company has transitioned this position to a new administrator and filed these changes with the IDPH (Illinois Department of Public Health). There are claims to be processed and invoiced when IDPH approves; through the uniform process and the new SCI administrator, the Company expects this to be resolved in the near future. The unaudited condensed consolidated interim financial statements of the Company do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classifications of liabilities that might be necessary should the Company be unable to continue as a going concern.

Short-Term Notes Payables

Short-Term Notes Payables	6 Months Ended
	Jun. 30, 2017
Debt Disclosure [Abstract]
Short-Term Notes Payables	NOTE 5 - SHORT-TERM NOTES PAYABLES Short-term notes payable at June 30, 2017 and December 31, 2016 consisted of the following: June 30, 2017 December 31, 2016 At Home and All Staffing acquisition note payable (1) 344,507 344,507 AOK Property Investments (2) 525,000 525,000 Note dated May 28, 2015 for $35,000; daily payment of $184.73 for 252 days 16,659 16,659 $ 886,166 $ 886,166 (1) The Company entered into a $344,507 promissory note (the “Trust Note”) with the Rose. M Gallagher Revocable Trust (the “Trust”) in conjunction with a settlement agreement dated December 23, 2014. The Trust Note bears interest at 11.0% per annum. The first payment of $25,000 was due on March 1, 2015, with the final principal and interest payment due on June 1, 2015. The Company is in default of the Trust Note and has a 90-day cure period. The Company paid $5,000 on April 8, 2015. If an event of default under the Trust Note occurs, the Trust may accelerate the Trust Note’s maturity date so that the unpaid principal amount, together with accrued interest, is immediately due in its entirety. In addition, the Company promised to pay $1,000 dollars as consideration for costs of collection of the Trust Note, including but not limited to attorneys’ fees paid or incurred on account of such collection, whether or not suit is filed with respect thereto and whether such cost or expense is paid or incurred, or to be paid or incurred, prior to or after the entry of judgment. Pursuant to the terms of the Trust Note, an event of default occurs if (i) the Company fails to make any payment required by the Trust Note when due, (ii) the Company fails to observe or perform any covenant, condition or agreement under the Trust Note, (iii) a proceeding with respect to the Company is commenced for the benefit of creditors, including but not limited to any bankruptcy or insolvency law; or (iv) the Company becomes insolvent. (2) On October 1, 2014, AOK Property Investments LLC (“AOK”), a third party lender, lent the Company and its subsidiary, Advanced Life Management, LLC (“ALM”) , an aggregate of $500,000. In consideration of AOK’s delivery of an aggregate of $500,000 to the Company and ALM, the Company and ALM executed and delivered a promissory note (the “AOK Note”) in favor of AOK in the aggregate principal amount of $500,000. The AOK Note was due on January 15, 2015 and bears interest in the amount of 500,000 shares of the Company’s common stock, which interest was due and payable on or before January 15, 2015. If the Company and ALM fail to pay any portion of principal or interest when due, interest will continue to accrue and be payable to AOK at the rate of 1,667 shares of Company common stock per day until all principal and accrued interest is fully paid. On July 10, 2015, the Company and AOK entered in an amended note agreement whereby AOK loaned the Company an additional $25,000 and extended the due date of the note to December 31, 2015, and the Company agreed to issue an additional 500,000 shares of common stock for failing to pay the principal and interest on the loan when originally due. The Company recorded the issuance of 500,000 shares of common stock to AOK at a value of $1,360,907. The loan was not repaid on its extended due date and is currently in default. If an event of default under the AOK Note occurs, AOK may accelerate the AOK Note’s maturity date so that the unpaid principal amount, together with accrued interest, is immediately due in its entirety. Pursuant to the terms of the AOK Note, an event of default occurs if (i) the Company or ALM fails to make any payment required by the AOK Note when due, (ii) the Company or SCI voluntarily dissolves or ceases to exist, or any final and non-appealable order or judgment is entered against the Company or SCI ordering its dissolution, (iii) the Company or ALM fails to pay, becomes insolvent or unable to pay, or admits in writing an inability to pay its debts as they become due, or makes a general assignment for the benefit of creditors; or (iv) a proceeding with respect to the Company or ALM is commenced for the benefit of creditors, including but not limited to any bankruptcy or insolvency law.

Convertible Notes

Convertible Notes	6 Months Ended
	Jun. 30, 2017
Debt Disclosure [Abstract]
Convertible Notes	NOTE 6 - CONVERTIBLE NOTES Convertible notes at June 30, 2017 and December 31, 2016 consist of the following: June 30, 2017 December 31, 2016 Convertible note dated December 16, 2015; non-interest bearing; convertible into shares of common stock at 50% of the market price on the date of conversion. 118,684 118,684 Convertible note dated March 10, 2016; interest of $3,333 due after 90 days; due August 28, 2017; convertible into shares of common stock at the lesser of $1.00 or 60% of the lowest trading price 25 days prior to conversion. - 9,363 Convertible note dated May 5, 2016; interest at 8% per annum; due May 5, 2017; convertible into shares of common stock at 65% of the lowest trading price 20 days prior to conversion. 46,625 46,625 Total convertible notes 165,309 174,672 Unamortized debt discount - (19,395 ) Convertible notes, net of discount $ 165,309 $ 155,277 Due to the variable conversion price associated with these convertible notes, the Company has determined that the conversion feature is considered derivative liabilities. The embedded conversion feature at inception is recorded as a derivative liability as of the date of issuance. The derivative liability was recorded as a debt discount up to the face amount of the convertible notes with the remaining amount being charge as a financing cost. The debt discount is being amortized over the term of the convertible notes. The Company recognized additional interest expense of $19,395 and $122,474 during the six months ended June 30, 2017 and 2016, respectively, related to the amortization of the debt discount. A rollfoward of the convertible note from December 31, 2016 to June 30, 2017 is below: Convertible notes, December 31, 2016 $ 155,277 Conversion to common stock (9,363 ) Amortization of debt discounts 19,395 Convertible notes, June 30, 2017 $ 165,309

Derivative Liability

Derivative Liability	6 Months Ended
	Jun. 30, 2017
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Liability	NOTE 7 - DERIVATIVE LIABILITY The convertible note discussed in Note 6 has a variable conversion price which results in the conversion feature being recorded as a derivative liability. The fair value of the derivative liability is recorded and shown separately under current liabilities. Changes in the fair value of the derivative liability is recorded in the statement of operations under other income (expense). The Company uses the Black-Scholes-Merton option pricing model with the following assumptions to measure the fair value of derivative liability at June 30, 2017 and December 31, 2016: June 30, 2017 December 31, 2016 Stock price $ 0.003 $ 0.0051 Risk free rate 0.59 % 0.59 % Volatility 325 % 325 % Conversion/Exercise price $ 0.0015 - 0.0018 $ 0.0025 - 0.007 Dividend rate 0 % 0 % Terms (years) 0.1 to 0.2 0.1 to 0.7 The following table represents the Company’s derivative liability activity for the period ended June 30, 2017: Derivative liability at December 31, 2016 $ 149,269 Change in fair value of derivative liability during period 18,798 Derivative liability at June 30, 2017 $ 168,067

Stockholders' Deficit

Stockholders' Deficit	6 Months Ended
	Jun. 30, 2017
Equity [Abstract]
Stockholders' Deficit	NOTE 8 - STOCKHOLDERS’ DEFICIT The Company has two classes of stock, preferred stock and common stock. There are 10,000,000 shares of $.0001 par value preferred shares authorized, 500,000 of which have been designated as 8% Convertible Preferred Stock as of May 7, 2015. The 500,000 shares of 8% Convertible Preferred Stock have the following the designations, rights, and preferences: ● The stated value of each share is $4.00, ● Holders of shares of 8% Convertible Preferred Stock do not have any voting rights, ● The shares pay quarterly dividends in arrears at the rate of 8% per annum and on each conversion date. Subject to certain conditions, the dividends are payable at our option in cash or such dividends shall be accreted to, and increase, the outstanding Stated Value, ● Each share is convertible into shares of our common stock at a conversion price of $4.00 per share, subject to adjustment discussed below, and ● The conversion price of the 8% Convertible Preferred is subject to proportional adjustment in the event of stock splits, stock dividends and similar corporate events. There were 198,473 shares of 8% Convertible Preferred Stock issued and outstanding as of June 30, 2017 and December 31, 2016. There are 100,000,000 shares of $.0001 par value common shares authorized. The Company has 81,407,673 and 69,569,444 issued and outstanding shares as of June 30, 2017 and December 31, 2016, respectively. During the six months ended June 30, 2017, the Company issued 8,589,229 shares for the conversion of $9,363 and $8,775 of convertible notes payable and accrued interest, respectively. In addition, the Company also issued 3,249,000 shares for the exercise of stock options.

Stock-Based Compensation

Stock-Based Compensation	6 Months Ended
	Jun. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock-Based Compensation	NOTE 9 - STOCK-BASED COMPENSATION The Company recognizes stock-based compensation expense in its statement of operations based on the fair value of employee stock options and stock grant awards as measured on the grant date. For stock options, the Company uses the Black-Scholes option pricing model to determine the value of the awards granted. The Company amortizes the estimated value of the options as of the grant date over the stock options’ vesting period, which is generally four years. The Company has estimated the value of common stock into which the options are exercisable at $4 per share for financial reporting purposes. This amount was determined based on the price our stock was sold for in past private placements, the minimum stock price required for listing on any Nasdaq market, and the amount also approximates a $85 million valuation for the entire Company, which is considered “micro-cap” by most equity analysts. The stock based compensation expense is an estimate and significant judgment was involved in attempting to determine the value of common stock. When a majority of the stock options were issued, the Company’s common stock has not traded publicly, and no stock was traded in private markets either, except for privately negotiated sales to the founder and other private investors of the company and the founder of the technology from which the company subsequently licensed rights. The Company does not have any offers for purchase of its common stock in any stage, and no stock is registered for resale with the Securities and Exchange Commission. The Company believes the only material estimate used in estimating the value stock options was the estimated fair value of the common stock, and that assumed volatility, term, interest rate and dividend yield changes would not result in material differences in stock option valuations. The Company recognized stock-based compensation expense of $15,000 and $921,144 for the six months ended June 30, 2017 and 2016, respectively, which were included in general and administrative expenses. As of June 30, 2017, there was $15,000 of total unrecognized compensation cost related to unvested stock-based compensation awards, which is expected to be recognized over the weighted average remaining vested period of approximately 0.75 years. The following is a summary of the outstanding options, as of June 30, 2017: Weighted Weighted Weighted Average Average Average Remaining Options Intrinsic Exercise Contractual Outstanding Value Price Life Outstanding, December 31, 2016 5,803,250 3.89 0.0001 0.5 Granted - Exercised (3,249,000 ) Forfeited/Expires - Outstanding, June 30, 2017 2,554,250 3.89 0.0001 1.95 Exercisable, June 30, 2017 2,554,250 3.89 0.0001 1.95

Related Party Transactions

Related Party Transactions	6 Months Ended
	Jun. 30, 2017
Related Party Transactions [Abstract]
Related Party Transactions	NOTE 10 - RELATED PARTY TRANSACTIONS On December 5, 2014, the Company and Synergistic, a major shareholder of the Company, agreed to cancel 796,671 shares of the Company’s common stock owned by Synergistic and forgive certain indebtedness owed by the Company to Synergistic in the amount of $1,018,618. In addition, the Company entered into an oral agreement to amend the licensing agreement entered into between the Company and Synergistic (the “Licensing Agreement”) to reduce the total amount of reimbursable distribution and commercialization expenses due under the Licensing agreement by $585,181 to $29,414,819 and defer the date of certain payment obligations by the Company under the Licensing Agreement as follows: (a) $5,000,000 no later than December 31, 2015; (b) An additional $7,500,000 no later than December 31, 2016; (c) An additional $10,000,000 no later than December 31, 2017; and (d) An additional $6,914,819 no later than December 31, 2018. No payments have been made to date. On May 7, 2015, the Company and Synergistic agreed to amend the Licensing Agreement to eliminate the Company’s $29,414,819 funding requirements under Article 3 and replace it with a requirement to pay a license fee in the amount of $10,000 upon completion and acceptance of each installation of the software at a location for each affiliate or subsidiary of the Company and the sum of $10,000 on each anniversary after each such installation during the period of time in which the software is used at such location. In addition, the Company will be responsible for the reasonable installation costs incurred by Synergistic in connection with the installation and setup of the software as required by the Company. The license fee may be paid in cash or the Company’s common stock. In addition, the Licensing Agreement was amended to delete the Company’s exclusive rights under such agreement. At June 30, 2017 and December 31, 2016, advances from related party was $435,592 and $403,092, respectively. These advances are non-interest bearing and payable upon demand.

Restatement of Previously Issue

Restatement of Previously Issued Financial Statements	6 Months Ended
	Jun. 30, 2017
Accounting Changes and Error Corrections [Abstract]
Restatement of Previously Issued Financial Statements	NOTE 11 – RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS On November 11, 2013, the Company entered into a stock purchase agreement with Behavioral Health Care Associates, Ltd. (“BHCA”) to purchase 100% of the issued and outstanding share of BHCA common stock for $4,550,000. The purchase price was to be paid in installments over a period of approximately 24 months. The Company originally recorded the purchase of BHCA on November 11, 2013 and began consolidating the operating results of BHCA from that date. The Company never made any of the required installment payments in accordance with the stock purchase agreement and the stock of BHCA was never transferred to the Company. As a result, the Company has determined that the financial statements of BHCA should have never been consolidated with those of the Company since the Company was never able to take control of BHCA due to non-payment of the purchase price. The prior year financial statements have been restated to remove BHCA from the consolidated financial statements of the Company. The following tables present the restated financial statements for the six months ended June 30, 2015. All the adjustments are a result of removing BHCA from the Company’s consolidated financial statements. As Originally Amount of Presented Restatement As Restated Revenues $ - $ - $ - Cost of revenues - - - Gross profit - - - Operating expenses: General and administrative expenses 1,121,219 - 1,121,219 Total operating expenses 1,121,219 - 1,121,219 Loss from operations (1,121,219 ) - (1,121,219 ) Other income (expense) Interest expense and financing costs (286,170 ) - (286,170 ) Change in fair value of derivative liability 92,922 - 92,922 Total other income (expenses) (193,248 ) - (193,248 ) Loss before provision for taxes (1,314,467 ) - (1,314,467 ) Provision for income taxes - - - Net loss from continuing operations (1,314,467 ) $ - $ (1,314,467 ) Discontinued operations, net of tax Gain from disposal of discontinued operation 4,239,585 (4,239,585 ) - Net income (loss) $ 2,925,118 (4,239,585 ) (1,314,467 ) Preferred stock dividend 31,669 - 31,669 Net loss attributed to common stockholders $ 2,893,449 $ (4,239,585 ) $ (1,346,136 ) Weighted average shares outstanding - basic and diluted 45,950,776 - 45,950,776 Income (loss) per share - basic and diluted $ 0.06 $ (0.09 ) $ (0.03 ) As Originally Amount of Presented Restatement As Restated OPERATING ACTIVITIES: Net income (loss) $ 2,925,118 $ (4,239,585 ) $ (1,314,467 ) Adjustments to reconcile net loss to net cash used in operating activities: Gain on discontinued operations (4,239,585 ) 4,239,585 - Depreciation 1,000 - 1,000 Stock options expense 921,144 - 921,144 Amortization of debt discount 122,474 - 122,474 Change in fair value of derivative liability (92,922 ) - (92,922 ) Financing costs associated with convertible note 135,533 - 135,533 Change in current assets and liabilities: Prepaid expenses and other current assets 150 - 150 Accounts payable (10,504 ) - (10,504 ) Accrued expenses 11,354 - 11,354 Net cash used in operating activities (226,238 ) - (226,238 ) INVESTING ACTIVITIES: Cash retained by discontinued operation (481,188 ) 481,188 - Net cash used in investing activities (481,188 ) 481,188 - FINANCING ACTIVITIES: Proceeds from convertible notes 77,500 - 77,500 Payment on notes payable (18,700 ) - (18,700 ) Cash overdraft 7,066 (6,624 ) 442 Advances from (payments to) related parties 166,996 - 166,996 Net cash provided by financing activities 232,862 (6,624 ) 226,238 NET INCREASE (DECREASE) IN CASH (474,564 ) 474,564 - CASH, BEGINNING BALANCE 474,564 (474,564 ) - CASH, ENDING BALANCE $ - $ - $ - CASH PAID FOR: Interest $ - $ - $ - Income taxes $ - $ - $ - NON-CASH INVESTING AND FINANCING ACTIVITIES: Convertible notes and accrued interest converted to common stock $ 24,000 $ - $ 24,000

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2017
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	NOTE 12 – COMMITMENTS AND CONTINGENCIES LG Capital Funding, LLC (“LG”) loaned approximately $50,000 on May 5, 2016 which is currently in default. LG filed a lawsuit in U.S. District Court Eastern District in New York. The parties are attempting to settle the matter and settlement negotiations have been going on for the past few weeks. A status hearing on the case is scheduled for August 14, 2017.

Summary of Significant Accoun18

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2017
Accounting Policies [Abstract]
Principles of Consolidation	PRINCIPLES OF CONSOLIDATION - The Company operates companies in the personal health care industry. The Company operates out of one service center serving the Chicago, Illinois area. The consolidated financial statements for the year ended December 31, 2016 include the accounts of the Company and its 100% owned subsidiary SCI, Significant intercompany accounts and transactions have been eliminated in consolidation.
Use of Estimates	USE OF ESTIMATES – The preparation of unaudited condensed consolidated interim financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates in these financial statements include allowance for doubtful accounts, the valuation of intangibles, valuation allowance for deferred taxes, estimated useful life of property and equipment and the fair value of stock and options issues for services and interest.
Cash	CASH - All cash is maintained with a major financial institution in the United States. Deposits with this bank may exceed the amount of insurance provided on such deposits. Temporary cash investments with an original maturity of three months or less are considered to be cash equivalents. The Company had no cash equivalents as of June 30, 2017 and December 31, 2016, respectively. The Company has not suffered any credit issues when deposits have exceeded the amount of insurance provided for such deposits.
Accounts Receivable	ACCOUNTS RECEIVABLE – Accounts receivable are recorded at estimated value, net of allowance for doubtful accounts. Accounts receivable are not interest bearing. The allowance for doubtful accounts is based upon management’s best estimate and past collection experience. For most accounts greater than 180 days, the Company carries a 100% allowance. Uncollectible accounts are charged off when all reasonable efforts to collect the accounts have been exhausted.
Property and Equipment	PROPERTY AND EQUIPMENT– Property and equipment is stated at cost. Depreciation is provided on a straight line basis over the estimated useful lives of the assets. Maintenance and repairs are charged to expense as incurred; major renewals and betterments are capitalized. When items of property and equipment are sold or retired, the related cost and accumulated depreciation are removed from the accounts, and any gain or loss is included in income.
Derivative Financial Instruments	DERIVATIVE FINANCIAL INSTRUMENTS — The Company evaluates all of its agreements to determine if such instruments have derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses the Black-Scholes-Merton option pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. As of June 30, 2017 and December 31, 2016, the Company’s only derivative financial instrument was an embedded conversion feature associated with convertible notes due to the conversion price being a percentage of the market price of the Company’s common stock.
Preferred Stock Subscription Payable	PREFERRED STOCK SUBSCRIPTION PAYABLE – During the years ended December 31, 2014 and 2013, an affiliate of the Company entered into subscription agreements with 13 investors. Pursuant to the terms of the subscription agreements, the affiliate agreed to issue shares of the Company’s 8% Convertible Preferred Stock that it was authorized to issue as of May 7, 2015. In exchange, the Company received aggregate proceeds from the investors of $652,462. Accordingly, the Company is obligated to issue an aggregate of 198,473 shares of 8% Convertible Preferred Stock to the investors with a stated value of $4.00 per share or an aggregate of $793,892. The net proceeds of $652,462 have been received by or on behalf of the Company and recorded as preferred stock subscription payable net of $141,430 of original issue discount related to such offering which amount was expensed. Upon obtaining the Certificate of Designation for the 8% Convertible Preferred Stock on May 7, 2015, the Company has included the aggregate amount of $793,892 of preferred stock as part of stockholders’ equity. Prior to May 7, 2015, the preferred stock subscription payable was included as a current liability.
Common Stock	COMMON STOCK - The Company records common stock issuances when all of the legal requirements for the issuance of such common stock have been satisfied.
Revenue Recognition	REVENUE RECOGNITION - Revenue related to services and administrative support services is recognized ratably at the time services have been performed and pre-approved by payer. Gross service revenue is recorded in the accounting records on an accrual basis at the provider’s established rates, regardless of whether the health care entity expects to collect that amount. The Company will reserve a provision for contractual adjustment and discounts and deducts the provision from gross service revenue. The Company believes that recognizing revenue at the time the services have been performed because the Company’s revenue policies meet the following four criteria in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 605-10-S25, Revenue Recognition
Cost of Revenues	COST OF REVENUES - Costs of revenues are comprised of fees paid to members of the Company’s medical staff, other direct costs including transcription, film and medical record obtainment and transportation; and other indirect costs including labor and overhead related to the generation of revenues.
Advertising Costs	ADVERTISING COSTS - The Company’s policy regarding advertising is to expense advertising when incurred.
Income Taxes	INCOME TAXES - The Company accounts for income taxes in accordance with ASC Topic 740, Income Taxes Under ASC 740, a tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded. The adoption had no effect on the Company’s consolidated financial statements.
Stock Based Compensation	STOCK BASED COMPENSATION - The Company has share-based compensation plans under which employees, consultants, suppliers and directors may be granted restricted stock, as well as options and warrants to purchase shares of Company common stock at the fair market value at the time of grant. Stock-based compensation cost to employees is measured by the Company at the grant date, based on the fair value of the award, over the requisite service period under ASC 718. For options issued to employees, the Company recognizes stock compensation costs utilizing the fair value methodology over the related period of benefit. Grants of stock to non-employees and other parties are accounted for in accordance with the ASC 505 at measurement date. For awards with service or performance conditions, the Company generally recognize expense over the service period or when the performance condition is met.
Loss Per Share	LOSS PER SHARE - Basic loss per share is computed by dividing net loss attributable to common stockholders by the weighted average common shares outstanding for the period. Diluted loss per share is computed giving effect to all potentially dilutive common shares. Potentially dilutive common shares may consist of incremental shares issuable upon the exercise of stock options and warrants and the conversion of notes payable to common stock. In periods in which a net loss has been incurred, all potentially dilutive common shares are considered anti-dilutive and thus are excluded from the calculation.
Financial Instruments	FINANCIAL INSTRUMENTS - FASB Accounting Standards Codification (ASC) 820 Fair Value Measurements and Disclosures ● Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. ● Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means. ● Level 3 - Inputs that are both significant to the fair value measurement and unobservable. Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of June 30, 2017 and December 31, 2016. The Company uses Level 2 inputs for its valuation methodology for its derivative liability as its fair value was determined by using the Black-Scholes-Merton pricing model based on various assumptions. The Company’s derivative liability is adjusted to reflect fair value at each period end, with any increase or decrease in the fair value being recorded in results of operations as adjustments to fair value of derivatives. At June 30, 2017 and December 31, 2016, the Company identified the following liability that is required to be presented on the balance sheet at fair value (see Note 8): Fair Value Fair Value Measurements at As of June 30, 2017 Description June 30, 2017 Using Fair Value Hierarchy Level 1 Level 2 Level 3 Derivative liability - conversion feature $ 168,067 $ - 168,067 - Total $ 168,067 $ - 168,067 - Fair Value Fair Value Measurements at As of December 31, 2016 Description December 31, 2016 Using Fair Value Hierarchy Level 1 Level 2 Level 3 Derivative liability - conversion feature $ 149,269 $ - 149,269 - Total $ 149,269 $ - 149,269 -
Recent Accounting Pronouncements	RECENT ACCOUNTING PRONOUNCEMENTS In January 2017, the FASB issued Accounting Standards Update (“ASU”) 2017-01, Business Combinations (Topic 805) Clarifying the Definition of a Business In November 2016, the FASB issued ASU 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash, In October 2016, the FASB issued ASU 2016-16, Income Taxes (Topic 740): Intra-Entity Transfer of Assets Other than Inventory In August 2016, the FASB issued ASU 2016-15 , Statement of Cash Flows (Topic 230), Classification of Certain Cash Receipts and Cash Payments In March 2016, the FASB issued ASU 2016-09, Stock Compensation (Topic 718), Improvements to Employee Share-Based Payment Accounting In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842 In August 2014, the FASB issued ASU 2014-15, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers Management does not believe that any recently issued, but not yet effective, accounting standards could have a material effect on the accompanying financial statements. As new accounting pronouncements are issued, the Company will adopt those that are applicable under the circumstances.
Reclassifications	RECLASSIFICATIONS - Certain prior year amounts have been reclassified to conform to the current period presentation. These reclassifications had no impact on net earnings, financial position or cash flows.

Summary of Significant Accoun19

Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Jun. 30, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Fair Value of Derivative Liability	At June 30, 2017 and December 31, 2016, the Company identified the following liability that is required to be presented on the balance sheet at fair value (see Note 8): Fair Value Fair Value Measurements at As of June 30, 2017 Description June 30, 2017 Using Fair Value Hierarchy Level 1 Level 2 Level 3 Derivative liability - conversion feature $ 168,067 $ - 168,067 - Total $ 168,067 $ - 168,067 - Fair Value Fair Value Measurements at As of December 31, 2016 Description December 31, 2016 Using Fair Value Hierarchy Level 1 Level 2 Level 3 Derivative liability - conversion feature $ 149,269 $ - 149,269 - Total $ 149,269 $ - 149,269 -

Balance Sheet Information (Tabl

Balance Sheet Information (Tables)	6 Months Ended
	Jun. 30, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Property and Equipment	Property and equipment, net at June 30, 2017 and December 31, 2016 consist of the following: June 30, 2017 December 31, 2016 Furniture and fixtures $ 3,940 $ 3,940 Office equipment 5,641 5,641 9,581 9,581 Less accumulated depreciation (3,692 ) (2,692 ) Property and equipment, net $ 5,889 $ 6,889

Short-Term Notes Payables (Tabl

Short-Term Notes Payables (Tables)	6 Months Ended
	Jun. 30, 2017
Debt Disclosure [Abstract]
Schedule of Short-Term Notes Payable	Short-term notes payable at June 30, 2017 and December 31, 2016 consisted of the following: June 30, 2017 December 31, 2016 At Home and All Staffing acquisition note payable (1) 344,507 344,507 AOK Property Investments (2) 525,000 525,000 Note dated May 28, 2015 for $35,000; daily payment of $184.73 for 252 days 16,659 16,659 $ 886,166 $ 886,166 (1) The Company entered into a $344,507 promissory note (the “Trust Note”) with the Rose. M Gallagher Revocable Trust (the “Trust”) in conjunction with a settlement agreement dated December 23, 2014. The Trust Note bears interest at 11.0% per annum. The first payment of $25,000 was due on March 1, 2015, with the final principal and interest payment due on June 1, 2015. The Company is in default of the Trust Note and has a 90-day cure period. The Company paid $5,000 on April 8, 2015. If an event of default under the Trust Note occurs, the Trust may accelerate the Trust Note’s maturity date so that the unpaid principal amount, together with accrued interest, is immediately due in its entirety. In addition, the Company promised to pay $1,000 dollars as consideration for costs of collection of the Trust Note, including but not limited to attorneys’ fees paid or incurred on account of such collection, whether or not suit is filed with respect thereto and whether such cost or expense is paid or incurred, or to be paid or incurred, prior to or after the entry of judgment. Pursuant to the terms of the Trust Note, an event of default occurs if (i) the Company fails to make any payment required by the Trust Note when due, (ii) the Company fails to observe or perform any covenant, condition or agreement under the Trust Note, (iii) a proceeding with respect to the Company is commenced for the benefit of creditors, including but not limited to any bankruptcy or insolvency law; or (iv) the Company becomes insolvent. (2) On October 1, 2014, AOK Property Investments LLC (“AOK”), a third party lender, lent the Company and its subsidiary, Advanced Life Management, LLC (“ALM”) , an aggregate of $500,000. In consideration of AOK’s delivery of an aggregate of $500,000 to the Company and ALM, the Company and ALM executed and delivered a promissory note (the “AOK Note”) in favor of AOK in the aggregate principal amount of $500,000. The AOK Note was due on January 15, 2015 and bears interest in the amount of 500,000 shares of the Company’s common stock, which interest was due and payable on or before January 15, 2015. If the Company and ALM fail to pay any portion of principal or interest when due, interest will continue to accrue and be payable to AOK at the rate of 1,667 shares of Company common stock per day until all principal and accrued interest is fully paid. On July 10, 2015, the Company and AOK entered in an amended note agreement whereby AOK loaned the Company an additional $25,000 and extended the due date of the note to December 31, 2015, and the Company agreed to issue an additional 500,000 shares of common stock for failing to pay the principal and interest on the loan when originally due. The Company recorded the issuance of 500,000 shares of common stock to AOK at a value of $1,360,907. The loan was not repaid on its extended due date and is currently in default. If an event of default under the AOK Note occurs, AOK may accelerate the AOK Note’s maturity date so that the unpaid principal amount, together with accrued interest, is immediately due in its entirety. Pursuant to the terms of the AOK Note, an event of default occurs if (i) the Company or ALM fails to make any payment required by the AOK Note when due, (ii) the Company or SCI voluntarily dissolves or ceases to exist, or any final and non-appealable order or judgment is entered against the Company or SCI ordering its dissolution, (iii) the Company or ALM fails to pay, becomes insolvent or unable to pay, or admits in writing an inability to pay its debts as they become due, or makes a general assignment for the benefit of creditors; or (iv) a proceeding with respect to the Company or ALM is commenced for the benefit of creditors, including but not limited to any bankruptcy or insolvency law.

Convertible Notes (Tables)

Convertible Notes (Tables)	6 Months Ended
	Jun. 30, 2017
Debt Disclosure [Abstract]
Schedule of Convertible Notes	Convertible notes at June 30, 2017 and December 31, 2016 consist of the following: June 30, 2017 December 31, 2016 Convertible note dated December 16, 2015; non-interest bearing; convertible into shares of common stock at 50% of the market price on the date of conversion. 118,684 118,684 Convertible note dated March 10, 2016; interest of $3,333 due after 90 days; due August 28, 2017; convertible into shares of common stock at the lesser of $1.00 or 60% of the lowest trading price 25 days prior to conversion. - 9,363 Convertible note dated May 5, 2016; interest at 8% per annum; due May 5, 2017; convertible into shares of common stock at 65% of the lowest trading price 20 days prior to conversion. 46,625 46,625 Total convertible notes 165,309 174,672 Unamortized debt discount - (19,395 ) Convertible notes, net of discount $ 165,309 $ 155,277
Schedule of Rollfoward Convertible Notes	A rollfoward of the convertible note from December 31, 2016 to June 30, 2017 is below: Convertible notes, December 31, 2016 $ 155,277 Conversion to common stock (9,363 ) Amortization of debt discounts 19,395 Convertible notes, June 30, 2017 $ 165,309

Derivative Liability (Tables)

Derivative Liability (Tables)	6 Months Ended
	Jun. 30, 2017
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Assumptions to Measure the Fair Value of Derivative Liability	The Company uses the Black-Scholes-Merton option pricing model with the following assumptions to measure the fair value of derivative liability at June 30, 2017 and December 31, 2016: June 30, 2017 December 31, 2016 Stock price $ 0.003 $ 0.0051 Risk free rate 0.59 % 0.59 % Volatility 325 % 325 % Conversion/Exercise price $ 0.0015 - 0.0018 $ 0.0025 - 0.007 Dividend rate 0 % 0 % Terms (years) 0.1 to 0.2 0.1 to 0.7
Schedule of Derivative Liability Activity	The following table represents the Company’s derivative liability activity for the period ended June 30, 2017: Derivative liability at December 31, 2016 $ 149,269 Change in fair value of derivative liability during period 18,798 Derivative liability at June 30, 2017 $ 168,067

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	6 Months Ended
	Jun. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule of Outstanding Options	The following is a summary of the outstanding options, as of June 30, 2017: Weighted Weighted Weighted Average Average Average Remaining Options Intrinsic Exercise Contractual Outstanding Value Price Life Outstanding, December 31, 2016 5,803,250 3.89 0.0001 0.5 Granted - Exercised (3,249,000 ) Forfeited/Expires - Outstanding, June 30, 2017 2,554,250 3.89 0.0001 1.95 Exercisable, June 30, 2017 2,554,250 3.89 0.0001 1.95

Restatement of Previously Iss25

Restatement of Previously Issued Financial Statements (Tables)	6 Months Ended
	Jun. 30, 2017
Accounting Changes and Error Corrections [Abstract]
Summary of Restated Financial Statements	The following tables present the restated financial statements for the six months ended June 30, 2015. All the adjustments are a result of removing BHCA from the Company’s consolidated financial statements. As Originally Amount of Presented Restatement As Restated Revenues $ - $ - $ - Cost of revenues - - - Gross profit - - - Operating expenses: General and administrative expenses 1,121,219 - 1,121,219 Total operating expenses 1,121,219 - 1,121,219 Loss from operations (1,121,219 ) - (1,121,219 ) Other income (expense) Interest expense and financing costs (286,170 ) - (286,170 ) Change in fair value of derivative liability 92,922 - 92,922 Total other income (expenses) (193,248 ) - (193,248 ) Loss before provision for taxes (1,314,467 ) - (1,314,467 ) Provision for income taxes - - - Net loss from continuing operations (1,314,467 ) $ - $ (1,314,467 ) Discontinued operations, net of tax Gain from disposal of discontinued operation 4,239,585 (4,239,585 ) - Net income (loss) $ 2,925,118 (4,239,585 ) (1,314,467 ) Preferred stock dividend 31,669 - 31,669 Net loss attributed to common stockholders $ 2,893,449 $ (4,239,585 ) $ (1,346,136 ) Weighted average shares outstanding - basic and diluted 45,950,776 - 45,950,776 Income (loss) per share - basic and diluted $ 0.06 $ (0.09 ) $ (0.03 ) As Originally Amount of Presented Restatement As Restated OPERATING ACTIVITIES: Net income (loss) $ 2,925,118 $ (4,239,585 ) $ (1,314,467 ) Adjustments to reconcile net loss to net cash used in operating activities: Gain on discontinued operations (4,239,585 ) 4,239,585 - Depreciation 1,000 - 1,000 Stock options expense 921,144 - 921,144 Amortization of debt discount 122,474 - 122,474 Change in fair value of derivative liability (92,922 ) - (92,922 ) Financing costs associated with convertible note 135,533 - 135,533 Change in current assets and liabilities: Prepaid expenses and other current assets 150 - 150 Accounts payable (10,504 ) - (10,504 ) Accrued expenses 11,354 - 11,354 Net cash used in operating activities (226,238 ) - (226,238 ) INVESTING ACTIVITIES: Cash retained by discontinued operation (481,188 ) 481,188 - Net cash used in investing activities (481,188 ) 481,188 - FINANCING ACTIVITIES: Proceeds from convertible notes 77,500 - 77,500 Payment on notes payable (18,700 ) - (18,700 ) Cash overdraft 7,066 (6,624 ) 442 Advances from (payments to) related parties 166,996 - 166,996 Net cash provided by financing activities 232,862 (6,624 ) 226,238 NET INCREASE (DECREASE) IN CASH (474,564 ) 474,564 - CASH, BEGINNING BALANCE 474,564 (474,564 ) - CASH, ENDING BALANCE $ - $ - $ - CASH PAID FOR: Interest $ - $ - $ - Income taxes $ - $ - $ - NON-CASH INVESTING AND FINANCING ACTIVITIES: Convertible notes and accrued interest converted to common stock $ 24,000 $ - $ 24,000

Organization and Basis of Pre26

Organization and Basis of Presentation (Details Narrative) - $ / shares	Dec. 05, 2014	Jun. 13, 2011	Jun. 30, 2017	Dec. 31, 2016
Common stock par value			$ 0.0001	$ 0.0001
Number of shares agree to issue for cancellation	796,671
Equity ownership percentage				100.00%
Common stock, shares issued			81,407,673	69,569,444
Common stock, shares outstanding			81,407,673	69,569,444
Synergistic Holdings LLC [Member]
Number of shares agreed to acquire by entity		17,000,000
Common stock par value		$ 0.0001
Equity ownership percentage		93.15%
Common stock, shares issued		18,250,000
Common stock, shares outstanding		18,250,000
Accelerated Venture Partners, LLC [Member]
Common stock par value		$ 0.0001
Number of stock shares for tender issuance		3,750,000
Number of shares agree to issue for cancellation		5,000,000
Equity ownership percentage		6.85%

Summary of Significant Accoun27

Summary of Significant Accounting Policies (Details Narrative)	May 07, 2015	Jun. 30, 2017USD ($)Integer$ / sharesshares	Dec. 31, 2014Integer	Dec. 31, 2013Integer	Dec. 31, 2016USD ($)$ / shares
Number of service centers | Integer		1
Ownership percentage					100.00%
Cash equivalents
Percentage of allowance for accounts greater than 180 days		100.00%
Percentage of convertible preferred stock authorized to issue	8.00%
Proceeds from investors		$ 435,592
Preferred stock, par value | $ / shares		$ 0.0001			$ 0.0001
Preferred stock aggregate amount		$ 793,892
Tax benefits description		greater than 50%
Investors [Member]
Percentage of convertible preferred stock authorized to issue		8.00%
Proceeds from investors		$ 652,462
Sale of stock issued during period | shares		198,473
Preferred stock, par value | $ / shares		$ 4
Preferred stock aggregate amount		$ 793,892
Preferred stock subscription payable		$ 141,430
8% Convertible Preferred Stock [Member]
Convertible preferred stock authorized to issue, date		May 7, 2015
Subscription Agreement [Member] | Investors [Member]
Number of investors entered into subscription agreement | Integer			13	13
Percentage of convertible preferred stock authorized to issue			8.00%	8.00%

Summary of Significant Accoun28

Summary of Significant Accounting Policies - Schedule of Fair Value of Derivative Liability (Details) - USD ($)	Jun. 30, 2017	Dec. 31, 2016
Derivative liability - conversion feature	$ 168,067	$ 149,269
Total	168,067	149,269
Level 1 [Member]
Derivative liability - conversion feature
Total
Level 2 [Member]
Derivative liability - conversion feature	168,067	149,269
Total	168,067	149,269
Level 3 [Member]
Derivative liability - conversion feature
Total

Balance Sheet Information (Deta

Balance Sheet Information (Details Narrative) - USD ($)	6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Depreciation expense	$ 1,000	$ 1,000

Balance Sheet Information - Sch

Balance Sheet Information - Schedule of Property and Equipment (Details) - USD ($)	Jun. 30, 2017	Dec. 31, 2016
Property and equipment, gross	$ 9,581	$ 9,581
Less accumulated depreciation	(3,692)	(2,692)
Property and equipment, net	5,889	6,889
Furniture and Fixtures [Member]
Property and equipment, gross	3,940	3,940
Office Equipment [Member]
Property and equipment, gross	$ 5,641	$ 5,641

Going Concern (Details Narrativ

Going Concern (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016	Dec. 31, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Net loss	$ 47,356	$ 572,368	$ 122,855	$ 1,314,467	$ 1,925,294
Accumulated deficit	$ 61,735,684		$ 61,735,684		$ 61,612,829

Short-Term Notes Payables (Deta

Short-Term Notes Payables (Details Narrative)	Jul. 10, 2015USD ($)shares	Apr. 08, 2015USD ($)	Oct. 02, 2014USD ($)shares	Jun. 30, 2017USD ($)Integer	Jun. 30, 2016USD ($)
Issuance of common stock				$ 18,138	$ 24,000
AOK Property Investments [Member]
Issuance of common stock, shares | shares	500,000
Issuance of common stock	$ 1,360,907
AOK Property Investments [Member] | Amended Note Agreement [Member]
Promissory note periodic payment	$ 25,000
Debt instrument due date	Dec. 31, 2015
Issuance of common stock, shares | shares	500,000
AOK Property Investments [Member] | Third Party Lender [Member]
Aggregate amount of property investments			$ 500,000
Issuance of common stock, shares | shares			1,667
Advanced Life Management [Member] | AOK Note [Member]
Promissory note principal amount			$ 500,000
Debt instrument due date			Jan. 15, 2015
Consideration of promissory note			$ 500,000
Debt instrument interest amount of shares | shares			500,000
At Home and All Staffing Acquisition Note Payable [Member]
Promissory note principal amount				$ 344,507
Promissory note interest rate				11.00%
Promissory note periodic payment				$ 25,000
Debt instrument due date				Mar. 1, 2015
Final debt instrument due date				Jun. 1, 2015
Promissory note default day | Integer				90
Repayment of debt		$ 5,000
Payment for cost of collection				$ 1,000

Short-Term Notes Payables - Sch

Short-Term Notes Payables - Schedule of Short-Term Notes Payable (Details) - USD ($)		Jun. 30, 2017	Dec. 31, 2016
Short-term notes payable		$ 886,166	$ 886,166
At Home and All Staffing Acquisition Note Payable [Member]
Short-term notes payable	[1]	344,507	344,507
AOK Property Investments [Member]
Short-term notes payable	[2]	525,000	525,000
Note dated May 28, 2015 for $35,000; Daily Payment of $184.73 for 252 Days [Member]
Short-term notes payable		$ 16,659	$ 16,659
[1]	The Company entered into a $344,507 promissory note (the "rust Note") with the Rose. M Gallagher Revocable Trust (the "Trust") in conjunction with a settlement agreement dated December 23, 2014. The Trust Note bears interest at 11.0% per annum. The first payment of $25,000 was due on March 1, 2015, with the final principal and interest payment due on June 1, 2015. The Company is in default of the Trust Note and has a 90-day cure period. The Company paid $5,000 on April 8, 2015.
[2]	On October 1, 2014, AOK Property Investments LLC ("AOK"), third party lender, lent the Company and its subsidiary, Advanced Life Management, LLC ("ALM") , an aggregate of $500,000. In consideration of AOK's delivery of an aggregate of $500,000 to the Company and ALM, the Company and ALM executed and delivered a promissory note (the "AOK Note") in favor of AOK in the aggregate principal amount of $500,000. The AOK Note was due on January 15, 2015 and bears interest in the amount of 500,000 shares of the Company's common stock, which interest was due and payable on or before January 15, 2015. If the Company and ALM fail to pay any portion of principal or interest when due, interest will continue to accrue and be payable to AOK at the rate of 1,667 shares of Company common stock per day until all principal and accrued interest is fully paid. On July 10, 2015, the Company and AOK entered in an amended note agreement whereby AOK loaned the Company an additional $25,000 and extended the due date of the note to December 31, 2015, and the Company agreed to issue an additional 500,000 shares of common stock for failing to pay the principal and interest on the loan when originally due. The Company recorded the issuance of 500,000 shares of common stock to AOK at a value of $1,360,907. The loan was not repaid on its extended due date and is currently in default.

Short-Term Notes Payables - S34

Short-Term Notes Payables - Schedule of Short-Term Notes Payable (Details) (Parenthetical) - Note Dated May 28, 2015 for $35,000; Daily Payment of $184.73 for 252 Days [Member] - USD ($)	6 Months Ended
	Jun. 30, 2017	May 28, 2015
Note principal amount		$ 35,000
Note daily payment	$ 185
Note due date	252 days

Convertible Notes (Details Narr

Convertible Notes (Details Narrative) - USD ($)	6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Debt Disclosure [Abstract]
Interest expense related to amortization of debt discount	$ 19,395	$ 122,474

Convertible Notes - Schedule of

Convertible Notes - Schedule of Convertible Notes (Details) - USD ($)	Jun. 30, 2017	Dec. 31, 2016
Convertible notes	$ 165,309	$ 174,672
Unamortized debt discount		(19,395)
Convertible notes, net of discount	165,309	155,277
Convertible Note Dated December 16, 2015 [Member]
Convertible notes	118,684	118,684
Convertible Note Dated March 10, 2016 [Member]
Convertible notes		9,363
Convertible Note Dated May 5, 2016 [Member]
Convertible notes	$ 46,625	$ 46,625

Convertible Notes - Schedule 37

Convertible Notes - Schedule of Convertible Notes (Details) (Parenthetical)	6 Months Ended	12 Months Ended
	Jun. 30, 2017USD ($)Integer$ / shares	Dec. 31, 2016USD ($)Integer$ / shares
Convertible Note Dated December 16, 2015 [Member]
Convertible note converted lowest trading price percentage	50.00%	50.00%
Convertible Note Dated March 10, 2016 [Member]
Convertible note converted lowest trading price percentage	60.00%	60.00%
Convertible note, interest rate | $	$ 3,333	$ 3,333
Convertible note interest free days	90 days	90 days
Convertible note due date	Aug. 28, 2017	Aug. 28, 2017
Convertible note trading days prior to conversion	25	25
Debt conversion price per share | $ / shares	$ 1	$ 1
Convertible Note Dated May 5, 2016 [Member]
Convertible note converted lowest trading price percentage	65.00%	65.00%
Convertible note due date	May 5, 2017	May 5, 2017
Convertible note trading days prior to conversion	20	20
Convertible note interest rate	8.00%	8.00%

Convertible Notes - Schedule 38

Convertible Notes - Schedule of Rollforward Convertible Notes (Details) - USD ($)	6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Debt Disclosure [Abstract]
Convertible notes, December 31, 2016	$ 155,277
Conversion to common stock	(9,363)
Amortization of debt discounts	19,395	$ 122,474
Convertible notes, June 30, 2017	$ 165,309

Derivative Liability - Schedule

Derivative Liability - Schedule of Assumptions to Measure the Fair Value of Derivative Liability (Details) - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2017	Dec. 31, 2016
Stock price	$ 0.003	$ 0.0051
Risk free rate	0.59%	0.59%
Volatility	325.00%	325.00%
Dividend rate	0.00%	0.00%
Minimum [Member]
Conversion/ Exercise price	$ 0.0015	$ 0.0025
Term (years)	1 month 6 days	1 month 6 days
Maximum [Member]
Conversion/ Exercise price	$ 0.0018	$ 0.007
Term (years)	2 months 12 days	8 months 12 days

Derivative Liability - Schedu40

Derivative Liability - Schedule of Derivative Liability Activity (Details)	6 Months Ended
	Jun. 30, 2017USD ($)
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative liability, beginning balance	$ 149,269
Change in fair value of derivative liability during period	18,798
Derivative liability, ending balance	$ 168,067

Stockholders' Deficit (Details

Stockholders' Deficit (Details Narrative) - USD ($)	6 Months Ended
	Jun. 30, 2017	Dec. 31, 2016
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, par value	$ 0.0001	$ 0.0001
Percentage of designated convertible preferred stock		8.00%
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, shares authorized	100,000,000	100,000,000
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares issued	81,407,673	69,569,444
Common stock, shares outstanding	81,407,673	69,569,444
Conversion of stock shares issued	8,589,229
Number of shares issued for exercise of stock options	(3,249,000)
Convertible Note Payable [Member]
Conversion of stock value issued	$ 9,363
Number of shares issued for exercise of stock options	3,249,000
Accrued Interest [Member]
Conversion of stock value issued	$ 8,775
8% Convertible Preferred Stock [Member]
Preferred stock, shares issued		198,473
Preferred stock, shares outstanding		198,473
8% Convertible Preferred Stock [Member]
Preferred stock, shares authorized	500,000	500,000
Preferred stock, par value	$ 4	$ 4
Percentage of designated convertible preferred stock	8.00%
Preferred stock conversion price	$ 4
Preferred stock, shares issued	198,473	198,473
Preferred stock, shares outstanding	198,473	198,473

Stock-Based Compensation (Detai

Stock-Based Compensation (Details Narrative) - USD ($)	6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Option exercisable price per share	$ 4
Proceeds from issuance of private placements	$ 85,000,000
Stock based compensation expense	15,000	$ 921,144
Unrecognized compensation cost related to unvested stock-based compensation awards	$ 15,000
Weighted average vesting period	9 months

Stock-Based Compensation - Sche

Stock-Based Compensation - Schedule of Outstanding Options (Details)	6 Months Ended
	Jun. 30, 2017$ / sharesshares
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Options Outstanding, Beginning Balance | shares	5,803,250
Options Outstanding, Granted | shares
Options Outstanding, Exercised | shares	(3,249,000)
Options Outstanding, Forfeited/Expires | shares
Options Outstanding, Ending Balance | shares	2,554,250
Options Outstanding, Exercisable | shares	2,554,250
Weighted Average Intrinsic Value, Beginning Balance | $ / shares	$ 3.89
Weighted Average Intrinsic Value, Ending Balance | $ / shares	3.89
Weighted Average Intrinsic Value, Exercisable | $ / shares	3.89
Weighted Average Exercise Price, Options Outstanding, Beginning Balance | $ / shares	0.0001
Weighted Average Exercise Price, Options Outstanding Ending Balance | $ / shares	0.0001
Weighted Average Exercise Price, Exercisable | $ / shares	$ 0.0001
Weighted Average Remaining Contractual Life, Beginning Balance	6 months
Weighted Average Remaining Contractual Life, Ending Balance	1 year 11 months 12 days
Weighted Average Remaining Contractual Life, Exercisable	1 year 11 months 12 days

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)	May 07, 2015	Dec. 05, 2014	Jun. 30, 2017	Dec. 31, 2016
Cancellation of shares		796,671
Amount owed to forgive indebtedness		$ 1,018,618
Advances from related party			$ 435,592	$ 403,092
Synergistic Licensing Agreement [Member]
License fee	$ 29,414,819
Common shares upon completion and acceptance of each installation of software	10,000
Installation of software cost	$ 10,000
December 31, 2015 [Member]
Deferred reimbursable distribution amount			5,000,000
December 31, 2016 [Member]
Deferred reimbursable distribution amount			7,500,000
December 31, 2017 [Member]
Deferred reimbursable distribution amount			10,000,000
December 31, 2018 [Member]
Deferred reimbursable distribution amount			6,914,819
Minimum [Member]
Reimbursable distribution and commercialization expenses			585,181
Maximum [Member]
Reimbursable distribution and commercialization expenses			$ 29,414,819

Restatement of Previously Iss45

Restatement of Previously Issued Financial Statements (Details Narrative) - USD ($)	Jun. 30, 2017	Dec. 31, 2016	Nov. 11, 2013
Ownership percentage		100.00%
Common stock value	$ 8,140	$ 6,957
Behavioral Health Care Associates, Ltd [Member]
Ownership percentage			100.00%
Common stock value			$ 4,550,000

Restatement of Previously Iss46

Restatement of Previously Issued Financial Statements - Summary of Restated Financial Statements (Details) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016	Dec. 31, 2016
Revenues
Cost of revenues
Gross profit
General and administrative expenses	34,175	416,059	82,175	1,121,219
Total operating expenses	34,175	416,059	82,175	1,121,219
Loss from operations	(34,175)	(416,059)	(82,175)	(1,121,219)
Interest expense and financing costs	(5,319)	(195,694)	(21,882)	(286,170)
Change in fair value of derivative liability	(7,862)	39,385	(18,798)	92,922
Total other income (expenses)	(13,181)	(156,309)	(40,680)	(193,248)
Loss before provision for taxes	(47,356)	(572,368)	(122,855)	(1,314,467)
Provision for income taxes
Net loss from continuing operations				(1,314,467)
Gain from disposal of discontinued operation
Net income (loss)	(47,356)	(572,368)	(122,855)	(1,314,467)	$ (1,925,294)
Preferred stock dividend	15,835	15,835	31,495	31,669
Net loss attributed to common stockholders	$ (63,191)	$ (588,203)	$ (154,350)	$ (1,346,136)
Weighted average shares outstanding - basic and diluted	80,447,453	46,761,216	78,768,026	45,950,776
Income (loss) per share - basic and diluted	$ 0	$ (0.01)	$ 0	$ (0.03)
Depreciation			$ 1,000	$ 1,000
Stock options expense			15,000	921,144
Amortization of debt discount			19,395	122,474
Change in fair value of derivative liability	$ 7,862	$ (39,385)	18,798	(92,922)
Financing costs associated with convertible note				135,533
Prepaid expenses and other current assets				(150)
Accounts payable			18,424	(10,504)
Accrued expenses			14,988	11,354
Net cash used in operating activities			(32,500)	(226,238)
Cash retained by discontinued operation
Net cash used in investing activities
Proceeds from convertible notes				77,500
Payment on notes payable				(18,700)
Cash overdraft				442
Advances from (payments to) related parties			32,500	166,996
Net cash provided by financing activities			32,500	226,238
NET INCREASE (DECREASE) IN CASH
CASH, BEGINNING BALANCE
CASH, ENDING BALANCE
Interest
Income taxes
Convertible notes and accrued interest converted to common stock			$ 18,138	24,000
As Originally Presented [Member]
Revenues
Cost of revenues
Gross profit
General and administrative expenses				1,121,219
Total operating expenses				1,121,219
Loss from operations				(1,121,219)
Interest expense and financing costs				(286,170)
Change in fair value of derivative liability				92,922
Total other income (expenses)				(193,248)
Loss before provision for taxes				(1,314,467)
Provision for income taxes
Net loss from continuing operations				(1,314,467)
Gain from disposal of discontinued operation				4,239,585
Net income (loss)				(1,314,467)
Preferred stock dividend				31,669
Net loss attributed to common stockholders				$ 2,893,449
Weighted average shares outstanding - basic and diluted				45,950,776
Income (loss) per share - basic and diluted				$ 0.06
Depreciation				$ 1,000
Stock options expense				921,144
Amortization of debt discount				122,474
Change in fair value of derivative liability				(92,922)
Financing costs associated with convertible note				135,533
Prepaid expenses and other current assets				150
Accounts payable				(10,504)
Accrued expenses				11,354
Net cash used in operating activities				(226,238)
Cash retained by discontinued operation				(481,188)
Net cash used in investing activities				(481,188)
Proceeds from convertible notes				77,500
Payment on notes payable				(18,700)
Cash overdraft				442
Advances from (payments to) related parties				166,996
Net cash provided by financing activities				226,238
NET INCREASE (DECREASE) IN CASH				(474,564)
CASH, BEGINNING BALANCE				474,564	474,564
CASH, ENDING BALANCE
Interest
Income taxes
Convertible notes and accrued interest converted to common stock				24,000
Amount of Restatement [Member]
Revenues
Cost of revenues
Gross profit
General and administrative expenses
Total operating expenses
Loss from operations
Interest expense and financing costs
Change in fair value of derivative liability
Total other income (expenses)
Loss before provision for taxes
Provision for income taxes
Net loss from continuing operations
Gain from disposal of discontinued operation				(4,239,585)
Net income (loss)				(4,239,585)
Preferred stock dividend
Net loss attributed to common stockholders				$ (4,239,585)
Weighted average shares outstanding - basic and diluted
Income (loss) per share - basic and diluted				$ (0.09)
Depreciation
Stock options expense
Amortization of debt discount
Change in fair value of derivative liability
Financing costs associated with convertible note
Prepaid expenses and other current assets
Accounts payable
Accrued expenses
Net cash used in operating activities
Cash retained by discontinued operation				481,188
Net cash used in investing activities				481,188
Proceeds from convertible notes
Payment on notes payable
Cash overdraft				(6,624)
Advances from (payments to) related parties
Net cash provided by financing activities				(6,624)
NET INCREASE (DECREASE) IN CASH				474,564
CASH, BEGINNING BALANCE				(474,564)	$ (474,564)
CASH, ENDING BALANCE
Interest
Income taxes
Convertible notes and accrued interest converted to common stock

Commitments and Contingencies (

Commitments and Contingencies (Details Narrative)	May 05, 2016USD ($)
LG Capital Funding, LLC [Member]
Loaned litigation amount	$ 50,000